Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Pioneering Composite Programmable Therapeutics
At CPTx, we develop new treatment paradigms across unmet medical challenges, with an initial focus on infectious diseases.The flexibility and precision of CPTx's platform support multivalent drug deve
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
January 2026 – November 2026 · 4 captures · latest observed messagingThe future of CAR-T is in vivo… powered by DNA.
15 January 2026 · The future of CAR-T is in vivo… powered by DNA.archived page
10 July 2026 · The future of CAR-T is in vivo… powered by DNA.archived page
12 July 2026 · The future of CAR-T is in vivo… powered by DNA.archived page
5 November 2026 · The future of CAR-T is in vivo… powered by DNA.current websiteHistorical capture not publicly available
Seen July 2025 · 1 captureBreakthroughs start with single strands.
At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug
April 2024 – January 2025 · 3 capturesEngineering the future of medicine with composite programmable therapeutics.
At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug